Editing Chlamydia (section)

==Prevention==
Prevention is by [[Sexual abstinence|not having sex]], the use of [[condom]]s, or having sex with only one other person, who is not infected.<ref name=CDCFact2016/>

===Screening===
For sexually active women who are not pregnant, screening is recommended in those under 25 and others at risk of infection.<ref name="AmFamPhys"/> Risk factors include a history of chlamydial or other sexually transmitted infection, new or multiple sexual partners, and inconsistent [[condom]] use.<ref name="USPSTF"/> For pregnant women, guidelines vary: screening women with age or other risk factors is recommended by the [[U.S. Preventive Services Task Force]] (USPSTF) (which recommends screening women under 25) and the [[American Academy of Family Physicians]] (which recommends screening women aged 25 or younger). The [[American College of Obstetricians and Gynecologists]] recommends screening all at risk, while the [[Centers for Disease Control and Prevention]] recommend universal screening of pregnant women.<ref name="AmFamPhys"/> The USPSTF acknowledges that in some communities there may be other risk factors for infection, such as ethnicity.<ref name="AmFamPhys"/> Evidence-based recommendations for screening initiation, intervals and termination are currently not possible.<ref name="AmFamPhys"/> For men, the USPSTF concludes evidence is currently insufficient to determine if regular screening of men for chlamydia is beneficial.<ref name="USPSTF"/> They recommend regular screening of men who are at increased risk for HIV or syphilis infection.<ref name="USPSTF"/> A [[Cochrane review]] found that the effects of screening are uncertain in terms of chlamydia transmission but that screening probably reduces the risk of pelvic inflammatory disease in women.<ref>{{cite journal | vauthors = Low N, Redmond S, Uusküla A, van Bergen J, Ward H, Andersen B, Götz H | title = Screening for genital chlamydia infection | journal = The Cochrane Database of Systematic Reviews | volume = 2016 | issue = 9 | pages = CD010866 | date = September 2016 | pmid = 27623210 | pmc = 6457643 | doi = 10.1002/14651858.CD010866.pub2 }}</ref>

In the United Kingdom the [[National Health Service|National Health Service (NHS)]] aims to:

# Prevent and control chlamydia infection through early detection and treatment of asymptomatic infection;
# Reduce onward transmission to sexual partners;
# Prevent the consequences of untreated infection;
# Test at least 25 percent of the sexually active under 25 population annually.<ref>{{cite web|url=http://www.chlamydiascreening.nhs.uk/ps/data/data_tables.html|title=National Chlamydia Screening Programme Data tables|access-date=2009-08-28|website=www.chlamydiascreening.nhs.uk|archive-url=https://web.archive.org/web/20090504185725/http://www.chlamydiascreening.nhs.uk/ps/data/data_tables.html|archive-date=2009-05-04|url-status=dead}}</ref>
# Retest after treatment.<ref name="DesaiWoodhall2015">{{cite journal | vauthors = Desai M, Woodhall SC, Nardone A, Burns F, Mercey D, Gilson R | title = Active recall to increase HIV and STI testing: a systematic review | journal = Sexually Transmitted Infections | volume = 91 | issue = 5 | pages = 314–323 | date = August 2015 | pmid = 25759476 | doi = 10.1136/sextrans-2014-051930 | doi-access = free | quote = Strategies for improved follow up care include the use of text messages and emails from those who provided treatment. }}</ref>